Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Karyopharm Therapeutics Inc (KPTI)

NASDAQ
Currency in USD
Disclaimer
1.085
-0.005(-0.46%)
Real-time Data

KPTI Comments

nobody here no comments ?
yeah nobody.!
Should reach USD 25 fairvalue by Mar
eanings 🚀🚀🚀
REVENUE BEAT 33.51M OVER EST 28.41M, undervalued based on upgrades - reported by Reuters June 23: H.C. Wainwright raises target price to $41 from $40, Jefferies raises target price to $35 from $34, JP Morgan raises target price to $37 from $31, RBC raises target price to $30 from $28, SVB Leerink raises target price to $31 from $29
bullish
KPTI. We like this stock and see it doubling from here in back half of 2020. Last: $18.99.
What is the target?
20.00 It just rose 70 % ! In one Day alone.... I expect a Big Discount. They knew what they were up too! That's why they drove the price up so astronomically for the OFFERING! Happens all the time...and we get the Shaft!
is it good to buy today?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.